Literature DB >> 1225335

Serum uric acid in hypertensive patients.

C J Bulpitt.   

Abstract

Both the average serum uric acid and annual increment were determined in 250 treated patients attending a hypertension clinic. The average serum uric acid was greater in men compared with women, in patients receiving a thiazide diuretic and in patients with a high average plasma urea. The mean annual increment in uric acid was close to zero (0.0017 mmol/litre per year) and was not related to sex, age, blood pressure control, diuretic therapy, or plasma urea. There was an unexplained positive association between annual increment and methyldopa therapy though this drug was not associated with a significantly high average serum uric acid. A table is presented giving the theoretical upper limits for average serum uric acid according to sex, plasma urea concentration, and whether or not a thiazide diuretic has been prescribed. It is hoped that this table will be of assistance in assessing the normality or otherwise of a high serum uric acid found in a hypertensive patient.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1225335      PMCID: PMC482943          DOI: 10.1136/hrt.37.12.1210

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  16 in total

1.  Another hypotensive agent--methyldopa.

Authors:  D DALEY; B EVANS
Journal:  Br Med J       Date:  1962-07-21

2.  Serum uric acid levels in hypertensive patients treated with guanethidine.

Authors:  L FRY; K A BARLOW
Journal:  Br Med J       Date:  1962-03-31

3.  Hyperuricaemia related to treatment of hypertension.

Authors:  C T DOLLERY; H DUNCAN; B SCHUMER
Journal:  Br Med J       Date:  1960-09-17

4.  Acute gouty arthritis precipitated by chlorothiazide.

Authors:  A ARONOFF
Journal:  N Engl J Med       Date:  1960-04-14       Impact factor: 91.245

5.  Gout and hyperuricaemia in rural and urban populations.

Authors:  A J POPERT; J V HEWITT
Journal:  Ann Rheum Dis       Date:  1962-06       Impact factor: 19.103

6.  Genetic and Endocrine Determinants of the Plasma Urate Level.

Authors:  C J Smyth; R M Stecher; W Q Wolfson
Journal:  Science       Date:  1948-11-05       Impact factor: 47.728

7.  Blood urea changes in hypertensive patients according to therapy given, blood pressure control, and serum potassium levels.

Authors:  C J Bulpitt
Journal:  Br Heart J       Date:  1974-04

8.  New Haven survey of joint diseases. The prediction of serum uric acid in a general population.

Authors:  R M Acheson; Y K Chan
Journal:  J Chronic Dis       Date:  1969-01

9.  Acute gout apparently precipitated by furosemide.

Authors:  D M Humphreys
Journal:  Br Med J       Date:  1966-04-23

10.  Clinical experience with chlorothiazide (diuril), with particular emphasis on untoward responses; a report of 121 cases studied over a 15 month period.

Authors:  L R DINON; Y S KIM; J B VANDER VEER
Journal:  Am J Med Sci       Date:  1958-11       Impact factor: 2.378

View more
  4 in total

1.  The prevalence of hyperuricemia and its correlates in an inland Chinese adult population, urban and rural of Jinan.

Authors:  Jianmin Yang; Zhendong Liu; Cheng Zhang; Yingxin Zhao; Shangwen Sun; Shujian Wang; Yuxia Zhao; Yun Zhang; Jifu Li; Fanghong Lu
Journal:  Rheumatol Int       Date:  2012-12-15       Impact factor: 2.631

2.  Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.

Authors:  M B Murphy; D Sugrue; I Trayner; S Kaufman; H Yasuhara; C T Dollery; G R Thompson
Journal:  Br Heart J       Date:  1984-06

Review 3.  Uric acid and cardiovascular risk.

Authors:  Daniel I Feig; Duk-Hee Kang; Richard J Johnson
Journal:  N Engl J Med       Date:  2008-10-23       Impact factor: 91.245

4.  Sugar-sweetened soda consumption, hyperuricemia, and kidney disease.

Authors:  Andrew S Bomback; Vimal K Derebail; David A Shoham; Cheryl A Anderson; Lyn M Steffen; Wayne D Rosamond; Abhijit V Kshirsagar
Journal:  Kidney Int       Date:  2009-12-23       Impact factor: 10.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.